About Luitpold
Luitpold is a company based in New York (United States) founded in 1910 was acquired by Daiichi Sankyo in June 1990. Luitpold has completed 2 acquisitions, including American Regent and Roxro Pharma.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
American Regent
& 1 more
-
Acquired by
Daiichi Sankyo
(Jun 01, 1990)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Luitpold
Unlock access to complete
Leadership Team
7 people
Software Development Team
2 people
Finance and Accounting
1 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Luitpold
Detailed funding history for Luitpold
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Luitpold
Luitpold has secured backing from 1 investor. Prominent investors backing the company include Daiichi Sankyo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical drugs are developed to address diverse medical needs.
|
Locked | Locked | Locked |
Investor details for Luitpold
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Luitpold
Luitpold has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include American Regent and Roxro Pharma.
Investment portfolio details for Luitpold
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Multiple pharmaceutical drugs are manufactured by PharmaForce.
|
Locked | Locked | 1999 | Locked | |
|
Acute pain drugs are developed from acquired failed candidates.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Luitpold
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Luitpold
Detailed financials for Luitpold
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Luitpold Comparisons
Peer comparison for Luitpold
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Luitpold
Detailed competitors of Luitpold
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Luitpold
Complete news archive for Luitpold
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Luitpold
Luitpold was founded in 1910.
Luitpold is headquartered in New York, United States. It is registered at New York, New York, United States.
Luitpold Pharmaceuticals engages in the development and marketing of variety of pharmaceutical products and medical devices. Product categories include injectables, ophthalmics, critical care drugs, antidotes and medicinal dyes. The company also provides custom product development for the treatment of acute pain; veterinary products; bone regeneration materials and graft products for the dental industry. It also offers contract manufacturing services. The company was acquired by Sankyo in 1991 and now operates as wholly owned subsidiary of Daiichi Sankyo.
Luitpold has made 2 acquisitions, including American Regent, and Roxro Pharma.
Luitpold has 1 investor. Key investors include Daiichi Sankyo.